You can buy or sell VBLT and other stocks, options, and ETFs commission-free!
Vascular Biogenics Ltd. Ordinary Shares, also called Vascular Biogenics, is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. The listed name for VBLT is Vascular Biogenics Ltd. Ordinary Shares.
52 Week High
52 Week Low
— per share
Expected Mar 18, Pre-Market